‌

US Patent 9447098 Pteridines as FGFR inhibitors

Patent 9447098 was granted and assigned to Astex Therapeutics Limited on September, 2016 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Astex Therapeutics Limited

Current Assignee

Astex Therapeutics Limited

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Valerio Berdini0

Virginie Sophie Poncelet0

Christopher Charles Frederick Hamlett0

Christopher William Murray0

Gordon Saxty0

Olivier Alexis Georges Querolle0

Patrick René Angibaud0

Date of Patent

September 20, 2016

Patent Application Number

14404175

Date Filed

May 30, 2013

Patent Citations Received

US Patent 11918576 Combination of an FGFR inhibitor and a CMET inhibitor

0

US Patent 11684620 Pharmaceutical compositions comprising N-(3,5-dimethoxyphenyl)-N′-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine

0

Patent Primary Examiner

Douglas M Willis

Patent abstract

The invention relates to new pteridine derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 9447098 Pteridines as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.